DIVISLAB Intraday Analysis...

DIVISLAB Share Price

Open 742.00 Change Price %
High 743.00 1 Day -7.05 -0.95
Low 729.00 1 Week -6.10 -0.83
Close 732.20 1 Month -430.05 -37.00
Volume 1272642 1 Year -338.50 -31.61
52 Week High 1381.60
52 Week Low 728.15
DIVISLAB Important Levels
Resistance 2 745.18
Resistance 1 739.83
Pivot 734.73
Support 1 724.57
Support 2 719.22
NSE INDIA Most Active Stocks
SUZLON 17.15 9.24%
FEDERALBNK 77.10 0.39%
JPASSOCIAT 10.25 0.49%
ESL 6.05 19.80%
ESL 6.05 19.80%
ESL 6.05 19.80%
ESL 6.05 19.80%
VISESHINFO 0.20 33.33%
IDEA 69.35 2.82%
TORNTPOWER 197.75 6.32%
More..
NSE INDIA Top Gainers Stocks
VKSPL 0.15 50.00%
VISESHINFO 0.20 33.33%
VIVIDHA 2.40 20.00%
ZUARI 337.60 19.99%
RUCHISOYA 24.05 19.95%
PREMIER 37.10 19.87%
ESL 6.05 19.80%
ESL 6.05 19.80%
ESL 6.05 19.80%
ESL 6.05 19.80%
More..
NSE INDIA Top Losers Stocks
AUSTRAL 0.35 -12.50%
NICCO 0.40 -11.11%
GOLDTECH 7.05 -7.24%
NHPC 27.80 -6.71%
ZENITHBIR 0.70 -6.67%
JIKIND 0.70 -6.67%
JAIHINDPRO 6.50 -6.47%
ITDC 279.50 -5.67%
JMA 181.55 -5.15%
MBLINFRA 56.10 -5.00%
More..

Divi s Laboratories Limited (NSE: DIVISLAB)

DIVISLAB Technical Analysis 5
As on 19th Jan 2017 DIVISLAB Share Price closed @ 732.20 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1111.89 & Strong Sell for SHORT-TERM with Stoploss of 1026.37 we also expect STOCK to react on Following IMPORTANT LEVELS.
DIVISLAB Target for January
1st Target up-side 1023.69
2nd Target up-side 1191.9
3rd Target up-side 1360.12
1st Target down-side 543.71
2nd Target down-side 375.5
3rd Target down-side 207.28
DIVISLAB Synopsis Technicals View
50 Day EMA N/A (Short Term)
N/A
100 Day EMA N/A (Mid Term) N/A
200 Day EMA N/A (Long Term) N/A
MACD (12 26 9) N/A N/A
RSI (14) N/A N/A
MFI (14) N/A N/A
CCI (20) N/A N/A
WILLIAM %R (14) N/A N/A
ADX (14) N/A N/A
PSAR N/A N/A
10 Day Avg Volume N/A
DIVISLAB Other Details
Segment EQ
Market Capital 68266049536.00
Sector Healthcare
Industry Drugs - Generic
Offical website http://www.divislabs.com
DIVISLAB Address
DIVISLAB
7-1-77/E/1/303, Divi Towers
Dharam Karan Road
Hyderabad, 500016
India
Phone: 91 40 2378 6300
Fax: 91 40 2378 6460
DIVISLAB Latest News
Interactive Technical Analysis Chart Divi s Laboratories Limited ( DIVISLAB NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Divi s Laboratories Limited
DIVISLAB Business Profile
Divis Labs is in the Pharmaceuticals sector. Established in the year 1990, with Research & Development as its prime fundamental, Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry. With five years of experience, expertise and a proven track-record of helping many companies with its turn-key and consulting strengths, Divis Laboratories established its first manufacturing facility in 1995. Built on a 500 acre site at Hyderabad (Unit-I). the plant comprises of 13 multi-purpose production blocks and has space for further growth and expansion. Divis Laboratories set up its second manufacturing facility at Visakhapatnam (Unit-II). in the year 2002 on a 350 acre site. The site has 14 multi purpose production blocks. The current market capitalisation stands at Rs 15,010.26 crore.The company has reported a consolidated sales of Rs 657.50 crore and a Net Profit of Rs 180.57 crore for the quarter ended Mar 2013. The company management includes Murali K Divi - Chairman & Managing Director, N V Ramana - Executive Director, Madhusudana Rao Divi - Director - Projects, Kiran S Divi - President & Director, K Satyanarayana - Director, S Vasudev - Director, G Suresh Kumar - Director. It is listed on the BSE with a BSE Code of 532488 and the NSE with an NSE Code of DIVISLAB. Its Registered office is at 7-1-77/E/1/303, Divi Towers,,Dharam Karan Road, Hyderabad,Andhra Pradesh - 500016.